63 related articles for article (PubMed ID: 22489943)
21. Risk assessment in haematopoietic stem cell transplantation: pre-transplant patient and donor factors: non-HLA genetics.
Dickinson AM
Best Pract Res Clin Haematol; 2007 Jun; 20(2):189-207. PubMed ID: 17448956
[TBL] [Abstract][Full Text] [Related]
22. Mismatch for the minor histocompatibility antigen HA-2 and GVHD occurrence in HLA-A*0201-positive Tunisian recipients of HSCs.
Sellami MH; Torjemane L; Espadas de Arias A; Kaabi H; Ladeb S; Ben Othman T; Poli F; Hmida S
Immunol Invest; 2010; 39(6):611-20. PubMed ID: 20653428
[TBL] [Abstract][Full Text] [Related]
23. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan KW; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
[TBL] [Abstract][Full Text] [Related]
24. RNA and protein expression of HLA-A(∗)23:19Q.
Gerritsen KE; Voorter CE; Joannes MO; Senden-Gijsbers BL; Agis F; Wieten L; Tilanus MG
Hum Immunol; 2015 Apr; 76(4):286-91. PubMed ID: 25676117
[TBL] [Abstract][Full Text] [Related]
25. Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.
Matsushita M; Yamazaki R; Ikeda H; Mori T; Sumimoto H; Fujita T; Okamoto S; Ikeda Y; Kawakami Y
Br J Haematol; 2006 Jan; 132(1):56-65. PubMed ID: 16371020
[TBL] [Abstract][Full Text] [Related]
26. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
27. Selection of unrelated donors for hematopoietic cell transplantation.
Field T; Anasetti C
Curr Hematol Rep; 2005 Jul; 4(4):270-5. PubMed ID: 16009041
[TBL] [Abstract][Full Text] [Related]
28. Dual expression of human leukocyte antigen molecules and the B7-1 costimulatory molecule (CD80) on human melanoma cells after particle-mediated gene transfer.
Albertini MR; Emler CA; Schell K; Tans KJ; King DM; Sheehy MJ
Cancer Gene Ther; 1996; 3(3):192-201. PubMed ID: 8725884
[TBL] [Abstract][Full Text] [Related]
29. Transduction of human renal carcinoma cells with human gamma-interferon gene via retroviral vector.
Nayak SK; McCallister T; Han LJ; Gangavalli R; Barber J; Dillman RO
Cancer Gene Ther; 1996; 3(3):143-50. PubMed ID: 8725877
[TBL] [Abstract][Full Text] [Related]
30. Expression profile of HLA-B*38:55Q allele.
Fusco C; Cervelli C; Dal Mas A; Canossi A; Azzarone R; Valdez O; Auriemma L; Madalese D; Maisto G; Toriello M; Penta de Vera d'Aragona R; Scimitarra M; Scarnecchia MA; Battistoni C; Fracassi D; Papola F
HLA; 2020 May; 95(5):449-456. PubMed ID: 31891446
[TBL] [Abstract][Full Text] [Related]
31. HLA-G*0105N null allele encodes functional HLA-G isoforms.
Le Discorde M; Le Danff C; Moreau P; Rouas-Freiss N; Carosella ED
Biol Reprod; 2005 Aug; 73(2):280-8. PubMed ID: 15814900
[TBL] [Abstract][Full Text] [Related]
32. Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells.
Gastl G; Finstad CL; Guarini A; Bosl G; Gilboa E; Bander NH; Gansbacher B
Cancer Res; 1992 Nov; 52(22):6229-36. PubMed ID: 1423266
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation.
Shaw BE; Maldonado H; Madrigal JA; Smith C; Petronzelli F; Mayor NP; Potter MN; Bodmer JG; Marsh SG
Tissue Antigens; 2004 May; 63(5):401-11. PubMed ID: 15104672
[TBL] [Abstract][Full Text] [Related]
34. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
35. Paradoxical downregulation of HLA-A expression by IFNγ associated with schizophrenia and noncoding genes.
Gu S; Fellerhoff B; Müller N; Laumbacher B; Wank R
Immunobiology; 2013 May; 218(5):738-44. PubMed ID: 23083632
[TBL] [Abstract][Full Text] [Related]
36. Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells.
Stam NJ; Kast WM; Voordouw AC; Pastoors LB; van der Hoeven FA; Melief CJ; Ploegh HL
J Immunol; 1989 Jun; 142(11):4113-7. PubMed ID: 2541206
[TBL] [Abstract][Full Text] [Related]
37. The amino acid variation of HLA-A*02:182 in a highly conserved region is predicted to be functionally similar to HLA-A*02:01:01:01 allele.
Wurm M; Tischer S; Immenschuh S; Bade-Doeding C; Blasczyk R; Eiz-Vesper B
Tissue Antigens; 2011 Feb; 77(2):149-50. PubMed ID: 20946190
[TBL] [Abstract][Full Text] [Related]
38. 5' and 3' untranslated regions contribute to the differential expression of specific HLA-A alleles.
René C; Lozano C; Villalba M; Eliaou JF
Eur J Immunol; 2015 Dec; 45(12):3454-63. PubMed ID: 26399450
[TBL] [Abstract][Full Text] [Related]
39. Allorecognition of an HLA-A*01 aberrant allele by an HLA identical family member carrying the HLA-A*0101 allele.
Almeciga I; Wang ZC; Zúñiga J; Fernandez-Viña M; Clavijo O; Araujo H; Romero V; Henry J; Ferrone S; Yunis EJ
J Immunol; 2006 Dec; 177(12):8643-9. PubMed ID: 17142764
[TBL] [Abstract][Full Text] [Related]
40. Establishment of a novel cell-based assay using HLA-transfected cells to detect HLA antibodies.
Nakano M; Takahashi D; Miyazaki T; Sato S; Ikuta K; Ikeda H; Kino S
J Immunol Methods; 2021 Aug; 495():113074. PubMed ID: 34051227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
